Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Journal of Chromatography
|
November 29, 1991
Use of anion-exchange chromatography and chromatofocusing to reveal the structural and functional heterogeneity of topoisomerase II in a HL-60 cell line resistant to multi-drug treatment
F Boege, F Gieseler, H Biersack, et al.
Toxicology Letters
|
February 27, 1999
Are topoisomerase II inhibitor-induced micronuclei in vitro a predictive marker for the compounds' ability to cause secondary leukemias after treatment?
H Stopper, G Boos, M Clark, et al.
Die Pharmazie
|
March 2, 2010
Temperature corrected transepithelial electrical resistance (TEER) measurement to quantify rapid changes in paracellular permeability
L-F Blume, M Denker, F Gieseler, et al.
International Journal of Colorectal Disease
|
May 30, 2003
Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail?
F Gieseler, P Rudolph, G Kloeppel, et al.
Thrombosis Research
|
May 11, 2016
PO-18 - Fibronectin EDA/EDB is expressed in adherent SCLC NCI-H69 cells and in pleural effusions of lung cancer patients: possible implication for drug resistance
U Salge-Bartels, M Heiden, R Seitz, et al.
Journal of Chromatography
|
November 13, 1992
Activation of topoisomerase II during partial purification by heparin-Sepharose chromatography
F Boege, F Gieseler, M Müller, et al.
European Journal of Biochemistry
|
December 1, 1993
A drug-resistant variant of topoisomerase II alpha in human HL-60 cells exhibits alterations in catalytic pH optimum, DNA binding and sub-nuclear distribution
F Boege, E Kjeldsen, F Gieseler, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 28, 2000
Induction of apoptosis by idarubicin: how important is the plasma peak?
F Gieseler, M Clark, K Stiebeling, et al.
Leukemia
|
November 11, 1999
Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage
F Gieseler, E Bauer, V Nuessler, et al.
Annals of Hematology
|
January 1, 1994
Cytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA binding
F Gieseler, H Biersack, T Brieden, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Journal of Chromatography
|
November 29, 1991
Use of anion-exchange chromatography and chromatofocusing to reveal the structural and functional heterogeneity of topoisomerase II in a HL-60 cell line resistant to multi-drug treatment
F Boege, F Gieseler, H Biersack, et al.
Toxicology Letters
|
February 27, 1999
Are topoisomerase II inhibitor-induced micronuclei in vitro a predictive marker for the compounds' ability to cause secondary leukemias after treatment?
H Stopper, G Boos, M Clark, et al.
Die Pharmazie
|
March 2, 2010
Temperature corrected transepithelial electrical resistance (TEER) measurement to quantify rapid changes in paracellular permeability
L-F Blume, M Denker, F Gieseler, et al.
International Journal of Colorectal Disease
|
May 30, 2003
Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail?
F Gieseler, P Rudolph, G Kloeppel, et al.
Thrombosis Research
|
May 11, 2016
PO-18 - Fibronectin EDA/EDB is expressed in adherent SCLC NCI-H69 cells and in pleural effusions of lung cancer patients: possible implication for drug resistance
U Salge-Bartels, M Heiden, R Seitz, et al.
Journal of Chromatography
|
November 13, 1992
Activation of topoisomerase II during partial purification by heparin-Sepharose chromatography
F Boege, F Gieseler, M Müller, et al.
European Journal of Biochemistry
|
December 1, 1993
A drug-resistant variant of topoisomerase II alpha in human HL-60 cells exhibits alterations in catalytic pH optimum, DNA binding and sub-nuclear distribution
F Boege, E Kjeldsen, F Gieseler, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 28, 2000
Induction of apoptosis by idarubicin: how important is the plasma peak?
F Gieseler, M Clark, K Stiebeling, et al.
Leukemia
|
November 11, 1999
Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage
F Gieseler, E Bauer, V Nuessler, et al.
Annals of Hematology
|
January 1, 1994
Cytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA binding
F Gieseler, H Biersack, T Brieden, et al.
Page
of 5